# Dose-finding of Rivaroxaban in Hemodialysis

> **NCT02047006** · PHASE4 · COMPLETED · sponsor: **AZ Sint-Jan AV** · enrollment: 18 (actual)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DRUG:** Rivaroxaban 10 mg

## Key facts

- **NCT ID:** NCT02047006
- **Lead sponsor:** AZ Sint-Jan AV
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-02
- **Final completion:** 2014-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02047006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02047006, "Dose-finding of Rivaroxaban in Hemodialysis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02047006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*